ABCL
Abcellera Biologics Inc
13.70$
-1.2%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
Abcellera Biologics Inc (ABCL) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -34 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.1 | -20 | -42 | -29 | -29 | -8.0 | -12 | -32 | -53 | -35 | -34 | -34 | -155 | |
| 7.4 | 9.1 | 6.8 | 38 | 38 | -18 | 6.6 | 7.1 | 7.2 | 9.0 | 8.7 | 5.2 | 30 | |
| 16 | 16 | 17 | 18 | 17 | 15 | 15 | 14 | 14 | 13 | 12 | 12 | 51 | |
| 14 | – | – | – | – | – | – | – | – | – | – | – | – | |
| 7.2 | 1.4 | -27 | -7.8 | -5.8 | -16 | 10 | -17 | -18 | -46 | -13 | -3.2 | -81 | |
| 20 | 14 | 24 | 20 | 19 | 16 | 11 | 13 | 8.9 | 9.8 | 3.8 | 2.1 | 25 | |
| -13 | -24 | 30 | 52 | 3.9 | 36 | 7.9 | -32 | 36 | 75 | -25 | 11 | 98 | |
| – | – | – | – | – | -1.6 | – | – | – | – | – | – | – | |
| 7.0 | – | – | – | – | – | – | – | – | – | – | – | – | |
| 6.6 | 3.8 | 2.8 | 2.6 | 3.2 | 4.1 | 6.0 | -3.4 | 7.4 | 4.1 | 7.2 | 14 | 32 | |
| -7.3 | -39 | -9.7 | 25 | -22 | 30 | 2.9 | -67 | -9.3 | 45 | -53 | -7.9 | -25 | |
| -20 | -34 | -66 | -49 | -48 | -24 | -22 | -46 | -62 | -45 | -37 | -36 | -179 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.